Clinical trial
Combination Radiation and PD-1 Inhibition in Metastatic or Recurrent RCC
NCT02962804 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Combination Radiation and PD-1 Inhibition in Metastatic or Recurrent RCC
- Lead sponsor
- University of Kansas Medical Center
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.